1. Home
  2. Pharma & Healthcare
  3. Global and United States Japanese Encephalitis Vaccines Market Report & Forecast 2022-2028

Global and United States Japanese Encephalitis Vaccines Market Report & Forecast 2022-2028

Publication Month: Mar 2022 | No. of Pages: 145 Published By: Reports Intellect
Single User License: US $ 3660
Corporate User License: US $ 7320

Summary:

Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.

Market Analysis and Insights: Global and United States Japanese Encephalitis Vaccines Market

This report focuses on global and United States Japanese Encephalitis Vaccines market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Japanese Encephalitis Vaccines market size is estimated to be worth US$ 220.9 million in 2022 and is forecast to a readjusted size of US$ 300.3 million by 2028 with a CAGR of 5.3% during the review period. Fully considering the economic change by this health crisis, by Type, Attenuated Vaccines accounting for % of the Japanese Encephalitis Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Adults was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Japanese Encephalitis Vaccines market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.

Global Japanese Encephalitis Vaccines Scope and Market Size

Japanese Encephalitis Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Japanese Encephalitis Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Japanese Encephalitis Vaccines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Japanese Encephalitis Vaccines market is segmented into

Attenuated Vaccines

Inactivated Vaccines

Segment by Application, the Japanese Encephalitis Vaccines market is segmented into

Adults

Children

Regional and Country-level Analysis

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Competitive Landscape and Japanese Encephalitis Vaccines Market Share Analysis

Japanese Encephalitis Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Japanese Encephalitis Vaccines business, the date to enter into the Japanese Encephalitis Vaccines market, Japanese Encephalitis Vaccines product introduction, recent developments, etc.

The major vendors covered:

Sanofi Pasteur

GlaxoSmithKline

Bharat Biotech

China National Biotec Group

Valneva Products

Table of Contents


1 Study Coverage

    1.1 Japanese Encephalitis Vaccines Product Introduction

    1.2 Global Japanese Encephalitis Vaccines Outlook 2017 VS 2022 VS 2028

        1.2.1 Global Japanese Encephalitis Vaccines Sales in US$ Million for the Year 2017-2028

        1.2.2 Global Japanese Encephalitis Vaccines Sales in Volume for the Year 2017-2028

    1.3 United States Japanese Encephalitis Vaccines Outlook 2017 VS 2022 VS 2028

        1.3.1 United States Japanese Encephalitis Vaccines Sales in US$ Million for the Year 2017-2028

        1.3.2 United States Japanese Encephalitis Vaccines Sales in Volume for the Year 2017-2028

    1.4 Japanese Encephalitis Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028

        1.4.1 The Market Share of United States Japanese Encephalitis Vaccines in Global, 2017 VS 2022 VS 2028

        1.4.2 The Growth Rate of Japanese Encephalitis Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028

    1.5 Japanese Encephalitis Vaccines Market Dynamics

        1.5.1 Japanese Encephalitis Vaccines Industry Trends

        1.5.2 Japanese Encephalitis Vaccines Market Drivers

        1.5.3 Japanese Encephalitis Vaccines Market Challenges

        1.5.4 Japanese Encephalitis Vaccines Market Restraints

    1.6 Study Objectives

    1.7 Years Considered

2 Market by Type

    2.1 Japanese Encephalitis Vaccines Market Segment by Type

        2.1.1 Attenuated Vaccines

        2.1.2 Inactivated Vaccines

    2.2 Global Japanese Encephalitis Vaccines Market Size by Type

        2.2.1 Global Japanese Encephalitis Vaccines Sales in Value, by Type (2017, 2022 & 2028)

        2.2.2 Global Japanese Encephalitis Vaccines Sales in Volume, by Type (2017, 2022 & 2028)

        2.2.3 Global Japanese Encephalitis Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    2.3 United States Japanese Encephalitis Vaccines Market Size by Type

        2.3.1 United States Japanese Encephalitis Vaccines Sales in Value, by Type (2017, 2022 & 2028)

        2.3.2 United States Japanese Encephalitis Vaccines Sales in Volume, by Type (2017, 2022 & 2028)

        2.3.3 United States Japanese Encephalitis Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)

3 Market by Application

    3.1 Japanese Encephalitis Vaccines Market Segment by Application

        3.1.1 Adults

        3.1.2 Children

    3.2 Global Japanese Encephalitis Vaccines Market Size by Application

        3.2.1 Global Japanese Encephalitis Vaccines Sales in Value, by Application (2017, 2022 & 2028)

        3.2.2 Global Japanese Encephalitis Vaccines Sales in Volume, by Application (2017, 2022 & 2028)

        3.3.3 Global Japanese Encephalitis Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    3.3 United States Japanese Encephalitis Vaccines Market Size by Application

        3.3.1 United States Japanese Encephalitis Vaccines Sales in Value, by Application (2017, 2022 & 2028)

        3.3.2 United States Japanese Encephalitis Vaccines Sales in Volume, by Application (2017, 2022 & 2028)

        3.3.3 United States Japanese Encephalitis Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global Japanese Encephalitis Vaccines Competitor Landscape by Company

    4.1 Global Japanese Encephalitis Vaccines Market Size by Company

        4.1.1 Top Global Japanese Encephalitis Vaccines Manufacturers Ranked by Revenue (2021)

        4.1.2 Global Japanese Encephalitis Vaccines Revenue by Manufacturer (2017-2022)

        4.1.3 Global Japanese Encephalitis Vaccines Sales by Manufacturer (2017-2022)

        4.1.4 Global Japanese Encephalitis Vaccines Price by Manufacturer (2017-2022)

    4.2 Global Japanese Encephalitis Vaccines Concentration Ratio (CR)

        4.2.1 Japanese Encephalitis Vaccines Market Concentration Ratio (CR) (2017-2022)

        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Japanese Encephalitis Vaccines in 2021

        4.2.3 Global Japanese Encephalitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

    4.3 Global Japanese Encephalitis Vaccines Manufacturing Base Distribution, Product Type

        4.3.1 Global Japanese Encephalitis Vaccines Manufacturers, Headquarters and Distribution of Producing Region

        4.3.2 Manufacturers Japanese Encephalitis Vaccines Product Type

        4.3.3 Date of International Manufacturers Enter into Japanese Encephalitis Vaccines Market

    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans

    4.5 United States Japanese Encephalitis Vaccines Market Size by Company

        4.5.1 Top Japanese Encephalitis Vaccines Players in United States, Ranked by Revenue (2021)

        4.5.2 United States Japanese Encephalitis Vaccines Revenue by Players (2020, 2021 & 2022)

        4.5.3 United States Japanese Encephalitis Vaccines Sales by Players (2020, 2021 & 2022)

5 Global Japanese Encephalitis Vaccines Market Size by Region

    5.1 Global Japanese Encephalitis Vaccines Market Size by Region: 2017 VS 2022 VS 2028

    5.2 Global Japanese Encephalitis Vaccines Market Size in Volume by Region (2017-2028)

        5.2.1 Global Japanese Encephalitis Vaccines Sales in Volume by Region: 2017-2022

        5.2.2 Global Japanese Encephalitis Vaccines Sales in Volume Forecast by Region (2023-2028)

    5.3 Global Japanese Encephalitis Vaccines Market Size in Value by Region (2017-2028)

        5.3.1 Global Japanese Encephalitis Vaccines Sales in Value by Region: 2017-2022

        5.3.2 Global Japanese Encephalitis Vaccines Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level

    6.1 North America

        6.1.1 North America Japanese Encephalitis Vaccines Market Size YoY Growth 2017-2028

        6.1.2 North America Japanese Encephalitis Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)

        6.1.3 U.S.

        6.1.4 Canada

    6.2 Asia-Pacific

        6.2.1 Asia-Pacific Japanese Encephalitis Vaccines Market Size YoY Growth 2017-2028

        6.2.2 Asia-Pacific Japanese Encephalitis Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)

        6.2.3 China

        6.2.4 Japan

        6.2.5 South Korea

        6.2.6 India

        6.2.7 Australia

        6.2.8 Taiwan

        6.2.9 Indonesia

        6.2.10 Thailand

        6.2.11 Malaysia

        6.2.12 Philippines

    6.3 Europe

        6.3.1 Europe Japanese Encephalitis Vaccines Market Size YoY Growth 2017-2028

        6.3.2 Europe Japanese Encephalitis Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)

        6.3.3 Germany

        6.3.4 France

        6.3.5 U.K.

        6.3.6 Italy

        6.3.7 Russia

    6.4 Latin America

        6.4.1 Latin America Japanese Encephalitis Vaccines Market Size YoY Growth 2017-2028

        6.4.2 Latin America Japanese Encephalitis Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)

        6.4.3 Mexico

        6.4.4 Brazil

        6.4.5 Argentina

    6.5 Middle East and Africa

        6.5.1 Middle East and Africa Japanese Encephalitis Vaccines Market Size YoY Growth 2017-2028

        6.5.2 Middle East and Africa Japanese Encephalitis Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)

        6.5.3 Turkey

        6.5.4 Saudi Arabia

        6.5.5 U.A.E

7 Company Profiles

    7.1 Sanofi Pasteur

        7.1.1 Sanofi Pasteur Corporation Information

        7.1.2 Sanofi Pasteur Description and Business Overview

        7.1.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2017-2022)

        7.1.4 Sanofi Pasteur Japanese Encephalitis Vaccines Products Offered

        7.1.5 Sanofi Pasteur Recent Development

    7.2 GlaxoSmithKline

        7.2.1 GlaxoSmithKline Corporation Information

        7.2.2 GlaxoSmithKline Description and Business Overview

        7.2.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2017-2022)

        7.2.4 GlaxoSmithKline Japanese Encephalitis Vaccines Products Offered

        7.2.5 GlaxoSmithKline Recent Development

    7.3 Bharat Biotech

        7.3.1 Bharat Biotech Corporation Information

        7.3.2 Bharat Biotech Description and Business Overview

        7.3.3 Bharat Biotech Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2017-2022)

        7.3.4 Bharat Biotech Japanese Encephalitis Vaccines Products Offered

        7.3.5 Bharat Biotech Recent Development

    7.4 China National Biotec Group

        7.4.1 China National Biotec Group Corporation Information

        7.4.2 China National Biotec Group Description and Business Overview

        7.4.3 China National Biotec Group Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2017-2022)

        7.4.4 China National Biotec Group Japanese Encephalitis Vaccines Products Offered

        7.4.5 China National Biotec Group Recent Development

    7.5 Valneva Products

        7.5.1 Valneva Products Corporation Information

        7.5.2 Valneva Products Description and Business Overview

        7.5.3 Valneva Products Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2017-2022)

        7.5.4 Valneva Products Japanese Encephalitis Vaccines Products Offered

        7.5.5 Valneva Products Recent Development

8 Industry Chain and Sales Channels Analysis

    8.1 Japanese Encephalitis Vaccines Industry Chain Analysis

    8.2 Japanese Encephalitis Vaccines Key Raw Materials

        8.2.1 Key Raw Materials

        8.2.2 Japanese Encephalitis Vaccines Distributors

    8.3 Japanese Encephalitis Vaccines Production Mode & Process

    8.4 Japanese Encephalitis Vaccines Sales and Marketing

        8.4.1 Japanese Encephalitis Vaccines Sales Channels

        8.4.2 Japanese Encephalitis Vaccines Distributors

    8.5 Japanese Encephalitis Vaccines Customers

9 Research Findings and Conclusion

10 Appendix

    10.1 Research Methodology

        10.1.1 Methodology/Research Approach

        10.1.2 Data Source

    10.2 Author Details

    10.3 Disclaimer

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets